Minimum Information About a Microarray Experiment

Minimum Information About a Microarray Experiment
Name	Minimum Information About a Microarray Experiment
Abbrev	MIAME
Introduced	2001
Developers	Microarray Gene Expression Data Society
Purpose	standardize microarray experiment reporting

Minimum Information About a Microarray Experiment is a reporting guideline that defines the essential metadata for describing microarray experiments to enable interpretation, verification, and reuse. It specifies the minimal information about samples, protocols, arrays, and data processing to support validation by peers and integration with public repositories. MIAME influenced policy decisions and database design across institutions, projects, and publishers.

Overview

MIAME prescribes structured descriptions of experimental design, biological materials, array design, hybridization protocols, measurement data, and normalization methods to promote transparency in transcriptomics. The guideline informed repository standards at institutions like the National Center for Biotechnology Information, European Bioinformatics Institute, Wellcome Trust, and projects such as the Human Genome Project and ENCODE Project. Major journals including Nature, Science, Cell, PLoS, and The Lancet adopted MIAME-aligned data policies, while funding agencies such as the National Institutes of Health, European Commission, and Wellcome Trust encouraged MIAME compliance.

History and Development

MIAME originated from discussions among researchers associated with organizations such as the Microarray Gene Expression Data Society, the International Society for Computational Biology, and working groups involving staff from the National Center for Biotechnology Information, European Bioinformatics Institute, and the Wellcome Trust. Seminal meetings in the early 2000s included contributors from laboratories led by figures connected to the Human Genome Project, and outputs were coordinated with databases like Gene Expression Omnibus and ArrayExpress. Influences came from earlier standardization efforts at institutions such as the National Institutes of Health, and policy dialogues with publishers including Nature Publishing Group and Public Library of Science.

Core Components and MIAME Requirements

MIAME defines six core components: experimental design; array design description; sample annotation; hybridization protocols; raw and processed data; and data transformation methods. Compliance requires documentation of biological source material linked to controlled vocabularies used by repositories such as Gene Ontology Consortium and standards initiatives like the Open Biological and Biomedical Ontology Foundry. Array design metadata often references platforms managed by companies and centers including Affymetrix, Agilent Technologies, and core facilities affiliated with institutions like Broad Institute and Wellcome Trust Sanger Institute. Data deposition workflows connect to infrastructures such as Gene Expression Omnibus, ArrayExpress, and computational resources at the European Bioinformatics Institute.

Implementation and Compliance

Practical implementation of MIAME involved development of submission formats, software tools, and community-driven validation by organizations including the Microarray Gene Expression Data Society and the International Society for Computational Biology. File formats and exchange standards were coordinated with initiatives like the Bioinformatics Open Source Conference and open-source projects supported by groups affiliated with the European Molecular Biology Laboratory and the National Institutes of Health. Publishers such as Nature, Science, and PLoS incorporated MIAME-like requirements into author guidelines, while repositories including Gene Expression Omnibus and ArrayExpress implemented validation checks and curation pipelines managed by staff with ties to the European Bioinformatics Institute and National Center for Biotechnology Information.

Impact on Data Sharing and Reproducibility

MIAME catalyzed large-scale data sharing by defining minimum metadata enabling reuse across projects like the Human Genome Project, the ENCODE Project, and disease-focused consortia funded by organizations such as the National Institutes of Health and the Wellcome Trust. By standardizing reporting, MIAME enhanced reproducibility in studies involving laboratories affiliated with universities and institutes such as the Broad Institute, Wellcome Trust Sanger Institute, Cold Spring Harbor Laboratory, and enabled meta-analyses published in venues including Nature Genetics and Genome Research. Repositories adopting MIAME-style metadata facilitated integrative analyses used by researchers at institutions including the European Bioinformatics Institute and the National Center for Biotechnology Information.

Criticisms and Limitations

Critiques of MIAME cited challenges in enforcement and variability in interpretability when applied across platforms from vendors like Affymetrix and Agilent Technologies or in community resources managed by centers such as the Broad Institute. Some argued MIAME's scope left gaps for next-generation technologies championed by initiatives like the 1000 Genomes Project and consortia supported by the National Institutes of Health, necessitating extensions and complementary standards such as those from the Functional Genomics Data Society. Practical burdens for laboratories, especially smaller groups at universities and hospitals, were highlighted in communications with funding bodies including the Wellcome Trust and the European Commission.

Category:Bioinformatics